{
  "ticker": "BMRN",
  "company_name": "BioMarin Pharmaceutical Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT01016392",
      "title": "Observational Study on the Long Term Safety of Kuvan\u00ae Treatment in Patients With Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or BH4 Deficiency",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) Deficiency",
      "start_date": "2009-12",
      "completion_date": "2021-05-31",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT05580692",
      "title": "A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV)",
      "status": "TERMINATED",
      "phase": "NA",
      "condition": "Hemophilia A",
      "start_date": "2023-03-14",
      "completion_date": "2024-07-31",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT02597881",
      "title": "Achondroplasia Natural History Multicenter Clinical Study",
      "status": "SUSPENDED",
      "phase": "",
      "condition": "Achondroplasia",
      "start_date": "2016-04",
      "completion_date": "2030-12-31",
      "enrollment": 0,
      "sponsor": "Johns Hopkins University"
    },
    {
      "nct_id": "NCT03424018",
      "title": "An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Achondroplasia",
      "start_date": "2017-12-12",
      "completion_date": "2031-06",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT06212947",
      "title": "A Multicenter Multinational Observational Study of Children With Hypochondroplasia",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Hypochondroplasia",
      "start_date": "2023-11-27",
      "completion_date": "2043-12-31",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT00225615",
      "title": "A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Phenylketonurias",
      "start_date": "2005-11",
      "completion_date": "2006-06",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT02156674",
      "title": "Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome",
      "status": "TERMINATED",
      "phase": "NA",
      "condition": "Maroteaux-Lamy Syndrome",
      "start_date": "2016-01-26",
      "completion_date": "2019-12-01",
      "enrollment": 0,
      "sponsor": "Masonic Cancer Center, University of Minnesota"
    },
    {
      "nct_id": "NCT01415427",
      "title": "Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Mucopolysaccharidosis IV A, Morquio A Syndrome, MPS IVA",
      "start_date": "2011-07",
      "completion_date": "2016-06-16",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT05270837",
      "title": "Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Phenylketonuria (PKU)",
      "start_date": "2022-06-17",
      "completion_date": "2027-10",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    },
    {
      "nct_id": "NCT03505125",
      "title": "A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Phenylketonuria (PKU)",
      "start_date": "2018-03-31",
      "completion_date": "2019-07-31",
      "enrollment": 0,
      "sponsor": "BioMarin Pharmaceutical"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "": 22,
      "NA": 3,
      "PHASE3": 9,
      "PHASE1, PHASE2": 2,
      "PHASE4": 2,
      "PHASE2": 9,
      "PHASE1": 3
    },
    "by_status": {
      "COMPLETED": 23,
      "TERMINATED": 7,
      "SUSPENDED": 1,
      "ACTIVE_NOT_RECRUITING": 6,
      "RECRUITING": 6,
      "ENROLLING_BY_INVITATION": 2,
      "UNKNOWN": 1,
      "APPROVED_FOR_MARKETING": 1,
      "WITHDRAWN": 3
    },
    "active_trials": 14,
    "completed_trials": 23,
    "conditions": [
      "Achondroplasia",
      "Alpha 1-Antitrypsin Deficiency",
      "Classical Phenylketonuria(PKU)",
      "Duchenne Muscular Dystrophy",
      "Heart Failure, Cardiovascular Disease",
      "Hemophilia A",
      "Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) Deficiency",
      "Hypochondroplasia",
      "Idiopathic Short Stature",
      "Isolated Systolic Hypertension, Endothelial Dysfunction",
      "Kidney Disease, Albuminuria",
      "Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2",
      "Late-onset Pompe Patients Untreated or Treated With rhGAA",
      "MPS IV A",
      "MPS IVA, Morquio Syndrome",
      "Maroteaux-Lamy Syndrome",
      "Morquio Disease, MPS - Mucopolysaccharidosis",
      "Morquio Disease, Mucopolysaccharidosis IV",
      "Mucopolysaccharidoses",
      "Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome, Scheie Syndrome",
      "Mucopolysaccharidosis IV A, Morquio A Syndrome, MPS IVA",
      "Mucopolysaccharidosis IV, Morquio A Disease",
      "Mucopolysaccharidosis IVA (Morquio A Syndrome)",
      "Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)",
      "Phenylketonuria",
      "Phenylketonuria (PKU)",
      "Phenylketonuria, Maternal",
      "Phenylketonurias",
      "Short Stature Homeobox- Containing Gene SHOX Deficiency, Noonan Syndrome, Turner Syndrome",
      "Solid Tumors, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma, Nonsmall Cell Lung Cancer"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:12.490466",
    "search_query": "BioMarin Pharmaceutical Inc.",
    "url": "https://clinicaltrials.gov/search?term=BioMarin+Pharmaceutical+Inc."
  }
}